ONK Therapeutics

Biotechnology Research • Galway, Co Galway, Ireland • 11-20 Employees

Company overview

Headquarters	Galway, Co Galway, Ireland
Website	onktherapeutics.com
NAICS	541714
SIC	873
Founded	2015
Employees	11-20
Socials

Key Contacts at ONK Therapeutics

Tony Killarney

Founder & Director

Eunan Maguire

Non Executive Director

ONK Therapeutics Email Formats

ONK Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	42.1%
{first name}@company.com	john@company.com	25.3%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	14.8%
{first name}{last name}@company.com	johndoe@company.com	10.2%
{last name}@company.com	doe@company.com	7.6%

About ONK Therapeutics

ONK Therapeutics, is an innovative cell therapy company dedicated to developing a next generation of off-the-shelf, dual-targeted NK cell therapy platform targeting hematological malignancies and solid tumors. The Company was founded in 2015, by Prof. O’Dwyer MD, of NUI Galway, an expert in translational multiple myeloma research, the tumour microenvironment, and exploitation of NK cells as cellular immunotherapy. Its core proprietary platform is based on a dual-targeted NK cell expressing both a chimeric antigen receptor (CAR) targeting a known tumour antigen and a TNF related apoptosis inducing ligand variant (TRAILv) targeting the death receptor pathway (i.e. DR4 or DR5). This promising new approach has the potential to enhance efficacy by addressing both intrinsic (e.g. CAR engagement of a tumor specific antigen) and extrinsic (e.g. signalling through the death receptor pathway) apoptotic pathways, and to reduce the susceptibility to possible target antigen escape through the engagement of tumor antigen independent TRAILv.

ONK Therapeutics revenue & valuation

Annual revenue	$1,454,435
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,700,000
Total funding	$21,500,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Manager

Director

Employees by Department

ONK Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore ONK Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-02-06	4	$21,500,000

Funding Insights

$21,500,000

Total funding amount

$21,500,000

Most recent funding amount

Number of funding rounds

ONK Therapeutics Tech Stack

Discover the technologies and tools that power ONK Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Contact Form 7

Form builders

PHP

Programming languages

Linkedin Sign-in

Authentication

WordPress

Blogs

core-js

JavaScript libraries

Sectigo

SSL/TLS certificate authorities

Google Analytics

Analytics

MySQL

Databases

RSS

Miscellaneous

Frequently asked questions

ONK Therapeutics is located in Galway, Co Galway, IE.

ONK Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

ONK Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

ONK Therapeutics has raised a total of $21,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at ONK Therapeutics

Tony Killarney

Founder & Director

Eunan Maguire

Non Executive Director

4.8

40,000 users